Literature DB >> 14635059

Detection of antigen-specific T cells by cytokine flow cytometry: the use of whole blood may underestimate frequencies.

Bodo Hoffmeister1, Torsten Bunde, Ina Maria Rudawsky, Hans-Dieter Volk, Florian Kern.   

Abstract

Antigen-specific T cells may be detected and enumerated by short-term ex vivo antigen-specific stimulation followed by cytokine flow cytometry. Most frequently, intracellular IFN-gamma is used to identify T cells specific for cytomegalovirus (CMV), Epstein-Barr virus or HIV. Some researchers use whole blood, others peripheral blood mononuclear cells (PBMC) in this assay; however, the performance of the two systems has never been directly compared. Blood was drawn from previously characterized healthy CMV-positive donors, and CMV-derived peptides or CMV lysate were used as stimulants. In an initial series of experiments, lithium-heparin was identified as the best coagulant to be used. Dose-response curves were established using concentrations between 0.1 and 40 microg/ml of peptides and between 0.1 and 20 microg/ml of virus lysate, respectively. IFN-gamma-positive T cells were expressed as percent of the reference population, and frequencies measured in whole blood and PBMC were compared. Maximum responses were consistently higher in PBMC than in whole blood and were reached at lower concentrations of stimulant. In several instances, responses identified with PBMC were not at all detected with whole blood. In summary, studies using whole blood in this type of assay are likely to underestimate the frequencies of antigen-specific T cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14635059     DOI: 10.1002/eji.200324223

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  10 in total

1.  CMV antigen-specific CD4+ and CD8+ T cell IFNgamma expression and proliferation responses in healthy CMV-seropositive individuals.

Authors:  Elizabeth Sinclair; Douglas Black; C Lorrie Epling; Alexander Carvidi; Steven Z Josefowicz; Barry M Bredt; Mark A Jacobson
Journal:  Viral Immunol       Date:  2004       Impact factor: 2.257

2.  A revised strategy for monitoring BKV-specific cellular immunity in kidney transplant patients.

Authors:  Benjamin J D Weist; Patrizia Wehler; Linda El Ahmad; Michael Schmueck-Henneresse; Jason M Millward; Mikalai Nienen; Avidan U Neumann; Petra Reinke; Nina Babel
Journal:  Kidney Int       Date:  2015-07-29       Impact factor: 10.612

3.  A model for harmonizing flow cytometry in clinical trials.

Authors:  Holden T Maecker; J Philip McCoy; Michael Amos; John Elliott; Adolfas Gaigalas; Lili Wang; Richard Aranda; Jacques Banchereau; Chris Boshoff; Jonathan Braun; Yael Korin; Elaine Reed; Judy Cho; David Hafler; Mark Davis; C Garrison Fathman; William Robinson; Thomas Denny; Kent Weinhold; Bela Desai; Betty Diamond; Peter Gregersen; Paola Di Meglio; Paola DiMeglio; Frank O Nestle; Frank Nestle; Mark Peakman; Federica Villanova; Federica Villnova; John Ferbas; Elizabeth Field; Aaron Kantor; Thomas Kawabata; Wendy Komocsar; Michael Lotze; Jerry Nepom; Hans Ochs; Raegan O'Lone; Deborah Phippard; Scott Plevy; Stephen Rich; Mario Roederer; Dan Rotrosen; Jung-Hua Yeh
Journal:  Nat Immunol       Date:  2010-11       Impact factor: 25.606

4.  A novel multi-parameter assay to dissect the pharmacological effects of different modes of integrin αLβ2 inhibition in whole blood.

Authors:  Karl Welzenbach; Riccardo V Mancuso; Stephan Krähenbühl; Gabriele Weitz-Schmidt
Journal:  Br J Pharmacol       Date:  2015-10-19       Impact factor: 8.739

5.  The role of CD4(+) T cells in BKV-specific T cell immunity.

Authors:  B J D Weist; M Schmueck; H Fuehrer; A Sattler; P Reinke; N Babel
Journal:  Med Microbiol Immunol       Date:  2014-07-23       Impact factor: 3.402

Review 6.  Isolation and preservation of peripheral blood mononuclear cells for analysis of islet antigen-reactive T cell responses: position statement of the T-Cell Workshop Committee of the Immunology of Diabetes Society.

Authors:  R Mallone; S I Mannering; B M Brooks-Worrell; I Durinovic-Belló; C M Cilio; F S Wong; N C Schloot
Journal:  Clin Exp Immunol       Date:  2010-10-05       Impact factor: 4.330

7.  Cytokine release assays for the prediction of therapeutic mAb safety in first-in man trials--Whole blood cytokine release assays are poorly predictive for TGN1412 cytokine storm.

Authors:  S Vessillier; D Eastwood; B Fox; J Sathish; S Sethu; T Dougall; S J Thorpe; R Thorpe; R Stebbings
Journal:  J Immunol Methods       Date:  2015-05-07       Impact factor: 2.303

8.  Tumor necrosis factor induces rapid down-regulation of TXNIP in human T cells.

Authors:  Trine B Levring; Martin Kongsbak-Wismann; Anna K O Rode; Fatima A H Al-Jaberi; Daniel V Lopez; Özcan Met; Anders Woetmann; Charlotte M Bonefeld; Niels Ødum; Carsten Geisler
Journal:  Sci Rep       Date:  2019-11-13       Impact factor: 4.379

9.  Robust T Cell Response Toward Spike, Membrane, and Nucleocapsid SARS-CoV-2 Proteins Is Not Associated with Recovery in Critical COVID-19 Patients.

Authors:  Constantin J Thieme; Moritz Anft; Krystallenia Paniskaki; Arturo Blazquez-Navarro; Adrian Doevelaar; Felix S Seibert; Bodo Hoelzer; Margarethe Justine Konik; Marc Moritz Berger; Thorsten Brenner; Clemens Tempfer; Carsten Watzl; Toni L Meister; Stephanie Pfaender; Eike Steinmann; Sebastian Dolff; Ulf Dittmer; Timm H Westhoff; Oliver Witzke; Ulrik Stervbo; Toralf Roch; Nina Babel
Journal:  Cell Rep Med       Date:  2020-08-29

10.  Marburg virus survivor immune responses are Th1 skewed with limited neutralizing antibody responses.

Authors:  Spencer W Stonier; Andrew S Herbert; Ana I Kuehne; Ariel Sobarzo; Polina Habibulin; Chen V Abramovitch Dahan; Rebekah M James; Moses Egesa; Stephen Cose; Julius Julian Lutwama; Leslie Lobel; John M Dye
Journal:  J Exp Med       Date:  2017-07-19       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.